The Arabidopsis CPD gene encodes a cytochrome P450 steroid side-chain hydroxylase (CYP90) that plays an essential role in the biosynthesis of the plant hormone brassinolide. Expression of the CPD gene is confined to cotyledons and leaf primordia in etiolated seedlings and detectable in the adaxial parenchyma of expanding leaves in light-grown plants. Transcription of the CPD gene is not affected by the plant growth factors auxin, ethylene, gibberellin, cytokinin, jasmonic acid and salicylic acid, but is specifically down-regulated by brassinolide in both dark and light. Steady-state mRNA levels of a CPD promoterdriven uidA reporter gene correlate with the expression of resident CPD gene in transgenic plants. Intermediates of the early and late C-6 oxidation pathways of brassinolide, carrying C-22 and C-23 side-chain hydroxyls, efficiently inhibit the activity of the CPD promoter. Repression of CPD transcription by brassinosteroids is sensitive to the
Introduction
Steroid hormones play an important role in the regulation of differentiation, sex determination, and maintenance of body homeostasis in animals. The biosynthesis of animal steroid hormones requires at least six different cytochrome P450 genes, the expression of which is tightly regulated by signalling mechanisms safeguarding cholesterol homeostasis (Honda et al., 1993; Waterman and Bischof, 1997) . High cholesterol levels in animals enhance the synthesis of oxidized cholesterol derivatives termed oxysterols. In turn, oxysterols induce an end-product repression of genes involved in steroid biosynthesis (Brown and Goldstein, 1997; Goldstein and Brown, 1990) .
Recently, genetic analysis of Arabidopsis and garden pea mutants has provided unequivocal evidence that brassinosteroids (BRs) are essential phytohormones (Clouse, 1996; Hooley, 1996) . Brassinolide, a product of campesterol oxidation, is required for the regulation of cell elongation, stress responses, male fertility, pigment biosynthesis, and numerous other developmental and physiological responses in higher plants (Mandava, 1988; Fujioka, 1993, 1997) . Our current knowledge on the control of biosynthesis and molecular action of BRs is largely based on studies of Arabidopsis mutants det2, cpd, dim and bri1 (Clouse, 1997; Fujioka and Sakurai, 1997a; Sasse, 1997; Yokota, 1997) . DET2 encodes a steroid 5α-reductase catalysing the synthesis of (24R)-24-methyl-5α-cholestan-3-one from (24R)-24-methylcholestan-4-en-3-one . In transgenic human cells, DET2 mediates the conversion of progesterone, testosterone and androstenedione to their 5α-reduced forms, suggesting a remarkable conservation of plant and animal steroidogenic enzymes (Li et al., 1996 . DIM1 is thought to control an early step in BR biosynthesis affecting the expression of a β-tubulin gene (Takahashi et al., 1995) . CPD encodes a cytochrome P450 (CYP90) required for C-23 hydroxylation of cathasterone to teasterone Szekeres et al., 1996) . BRI1 codes for a putative receptor kinase carrying an N-terminal endoplasmic reticulum localization signal followed by leucine-rich repeats essential for BR perception . Molecular analysis of these mutants indicates that deficiencies in BR biosynthesis and perception not only cause dramatic phenotypic alterations, but also induce significant changes in gene expression leading for example to the activation of certain light-induced genes in the dark and de-repression of many stress-regulated genes in the light Li et al., 1996; Szekeres et al., 1996) . Characterization of BR-induced genes suggests that BRs may control gene expression either at the transcriptional (Xu et al., 1995) or post-transcriptional level (Zurek and Clouse, 1994 ).
Here we demonstrate that side-chain hydroxylated BRs, including brassinolide, negatively regulate the transcription of the CPD steroid hydroxylase gene in Arabidopsis. Downregulation of CPD transcription by BRs is inhibited by cycloheximide. The data suggest an intriguing analogy between end-product control of genes involved in steroid biosynthesis in plants and animals.
Results

Transcription of the CPD gene is repressed by brassinolide
Recently, it has been found that the Arabidopsis CPD gene encodes a cytochrome P450 (CYP90) showing sequence similarity to animal steroid hydroxylases. Feeding of the cpd mutant with biosynthetic precursors of brassinolide indicated that CYP90 may catalyse the conversion of cathasterone to teasterone by C-23 hydroxylation . The CPD gene appeared thus to control an essential step in brassinolide biosynthesis. To determine whether BR biosynthesis is regulated at the level of CPD gene expression, a 965 bp DNA segment, carrying the CPD promoter and 5Ј-untranslated leader sequences, was cloned upstream of an uidA reporter gene in the promoter test vector pPCV812 (Koncz et al., 1994) . Following introduction of the reporter gene construct into Arabidopsis plants, RNA hybridizations were performed to compare the levels of steady-state mRNAs synthesized from the resident CPD gene and the CPD promoter-driven uidA reporter gene (Figure 1 ). The levels of CPD and uidA mRNAs were comparable in both dark-and light-grown transgenic seedlings, indicating a potential for use of the CPD promoteruidA reporter construct in gene expression studies.
To search for factors regulating CPD gene expression, preliminary assays were carried out by monitoring the GUS reporter enzyme levels in seedlings exposed to different growth hormones in liquid MS medium (Figure 2c ). Auxin (indole-3-acetic acid, IAA and α-naphthaleneacetic acid, NAA), gibberellin (GA 3 ), and cytokinin (6-benzylaminopurine, BAP) did not affect significantly the levels of GUS enzyme produced by the CPD promoter-uidA reporter construct. Methyl-jasmonate, salicylic acid, 1-aminocyclopropane-1-carboxylic acid (an ethylene precursor) and ergosterol (a fungal steroid) also proved to be inactive in Figure 1 . Transcription of the CPD gene and CPD promoter-driven uidA reporter gene is down-regulated by brassinolide in a cycloheximidedependent fashion in transgenic plants.
Seedlings were grown for 8 days in the light (a,c) or in the dark (b,d), then transferred into liquid MS medium. Brassinolide was added by dilution of 1 mM stock in ethanol at a final concentration of 1 µM (BL), whereas control samples were treated with 0.1% ethanol (CTR) or with 100 µM cycloheximide (CHX). To monitor the effect of inhibition of protein synthesis, seedlings were treated with 100 µM cycloheximide before the addition of 1 µM brassinolide (CHX ϩ BL). Samples for RNA preparation and Northern blotting were collected after 0, 2. 4 and 6 h of treatment. Equal loading of RNA blots was monitored by hybridization with a control probe as described in Experimental procedures, then the blots were hybridized with CPD (a,b) and uidA (c,d) probes. Quantitative hybridization data are plotted as percentage of the zero-time control values. these assays (data not shown). However, brassinolide treatment of the seedlings resulted in a drastic reduction of GUS enzyme level, suggesting that the activity of the CPD promoter may be controlled by the end-product of BR biosynthesis. Titration assays showed that the inhibitory effect of brassinolide is concentration-dependent. Concentrations as low as 1 nM brassinolide resulted in 50% inhibition, and a maximum level of about 90% reduction of GUS activity was detected in seedlings exposed to brassinolide concentrations higher than 0.1 µM (Figure 2a) .
To confirm that BR-mediated down-regulation of the CPD promoter-uidA reporter indeed resulted from a repression of CPD transcription, RNA samples were prepared from etiolated and light-grown seedlings incubated with 1 µM brassinolide for 0, 2, 4 and 6 h with or without previous treatment with 100 µM cycloheximide for 30 min (Koshiba et al., 1995) . Control samples were incubated with or without cycloheximide in MS medium. To simultaneously detect temporal changes induced by brassinolide and cycloheximide in the expression of resident CPD gene and the CPD promoter-uidA reporter construct, the RNA samples were subjected to Northern hybridization using the CPD cDNA and uidA coding region as probes. Exposure of lightgrown seedlings to brassinolide reduced the CPD RNA level to 10% of the untreated control within 2 h and no further decrease was seen following 4 and 6 h of treatment ( Figure 1 ). Brassinolide-induced decrease of the steadystate CPD RNA level was slightly slower in dark-grown seedlings. The temporal expression pattern of the CPD promoter-driven uidA reporter gene, carrying 3Ј-untranslated sequences from the nopaline synthase gene (Koncz et al., 1994) , showed a remarkable similarity to that of the CPD gene. In etiolated seedlings, the uidA mRNA levels gradually decreased during the 6 h of brassinolide treatment, whereas the uidA mRNA was barely detectable in light-grown seedlings after 2 h of exposure to brassinolide.
Repression of CPD transcription by brassinolide requires de novo protein synthesis
Inhibition of protein synthesis by cycloheximide for 30 min resulted in a transient increase in the CPD and uidA RNA levels, which was followed by a gradual decrease during the 6 h incubation period. Depletion of both transcript pools was somewhat faster in light-grown seedlings than © Blackwell Science Ltd, The Plant Journal, (1998), 14, [593] [594] [595] [596] [597] [598] [599] [600] [601] [602] in etiolated ones: after 6 h their respective values were about 10% and 20% of their initial levels (Figure 1 ). Whereas treatment of the plants with brassinolide for 2 h caused a substantial inhibition of CPD and uidA gene expression both in light and dark, in plants incubated with cycloheximide for 30 min and then with brassinolide this effect was completely abolished and steady-state transcript levels were identical with those detected in the cycloheximidetreated control. Therefore, the data suggested that inhibition of either protein synthesis or transcript degradation (Gil and Green, 1996) by cycloheximide could prevent a down-regulation of CPD transcript levels by brassinolide. The level of steady-state mRNAs derived from both CPD and CPD promoter-driven uidA genes showed a decrease, rather than an increase, in plants incubated for longer time periods with cycloheximide. The results thus indicated that brassinolide affected either the regulation of CPD promoter activity or increased non-specific turnover of unrelated CPD and uidA mRNAs. The inhibition of brassinolidemediated down-regulation of CPD transcription by cycloheximide suggested a requirement for de novo synthesis of a negative regulatory factor.
Tissue-specific regulation of CPD gene expression
Pools of transgenic F 2 seedlings carrying the CPD promoter-uidA reporter construct displayed GUS enzyme activities between 1.2 ϫ 10 2 and 7.6 ϫ 10 3 nmol of 4-methylumbelliferyl glucuronide min -1 mg -1 protein. These pools were used for monitoring temporal and spatial activity of the CPD promoter in etiolated and light-grown seedlings (Jefferson, 1987) . During early development, similar GUS staining patterns were observed in both etiolated and light-grown seedlings (Figure 3) . GUS activity appeared only in the cotyledons three days after imbibition and increased throughout the first week of seedling development. Occasionally, some weak GUS staining was also observed in the uppermost section of hypocotyls in © Blackwell Science Ltd, The Plant Journal, (1998), 14, 593-602 light-grown plants, as well as in the apical hook of darkgrown seedlings, but never occurred in lower sections of hypocotyl or in the roots. Ten days after germination, GUS staining appeared in the leaf primordia and showed a concomitant decrease in the cotyledons. Seedlings grown in the presence of 1 µM brassinolide showed a similar distribution but much lower level of GUS activity, and intense staining was seen only in the expanding leaf primordia (Figure 3b) . At later stages of plant development in the light, the GUS staining was confined to leaf buds and young rosette leaves, but was absent in petioles. In ageing leaves, the GUS activity gradually decreased and became restricted to the leaf margins. Leaf-blade crosssections showed a high GUS activity in mesophyll cells, especially those of the palisade parenchyma, and the stomatal guard cells of adaxial epidermis (Figure 4) . In the inflorescence, GUS activity was found in cauline leaves and sepals. No GUS staining was observed in other flower organs, siliques, peduncles and mature roots (Figures 3  and 4) .
Feed-back regulation of CPD promoter by products of phytosterol oxidation pathways
Developmental activation of the CPD promoter appears to be independent of light signalling because similar levels of CPD and uidA transcripts (Figure 1 ), as well as identical GUS staining of cotyledons (Figure 3 ), were detected in seedlings grown for 8 days in the dark and light. Thus, GUS enzyme activities measured in young seedlings seemed to correlate with the activity of the CPD promoter. To test whether the GUS reporter is indeed suitable for monitoring BR-induced down-regulation of the CPD promoter, seedlings were germinated in the presence or absence of 1 µM brassinolide for 8 days in both dark and light. Histological staining (Figure 3 ) and fluorimetric enzyme assays (Figure 2c) showed that brassinolide treatment caused a 90% reduction of GUS enzyme activity in seedlings grown in both dark (data not shown) and light.
To search for further compounds regulating the CPD promoter, three pools of 20 seedlings were grown for 8 days with BRs added at 1 µM concentration, then subjected to GUS assays using untreated seedlings as control. Except for campesterol and campestanol, intermediates of the early C-6 oxidation pathway of brassinolide biosynthesis, including cathasterone, teasterone, 3-dehydroteasterone, typhasterol and castasterone resulted in a significant reduction of CPD promoter-dependent GUS activity (Figure 2b ). The extent of CPD inhibition observed with these BRs correlated well with their biological activity detected in other bioassays (Fujioka et al., 1995 . A reduction of GUS activity was analogously detected with BR intermediates of the late C-6 oxidation pathway . In comparison to BRs involved in the early C-6 oxidation pathway, their 6-deoxo derivatives and epi-stereoisomers showed lower activities. Changes in the stereoisomery of side-chain substitutions and the lack of C-6 oxidation also reduced, but did not abolish, the CPD inhibitory activity of BRs derived from campesterol ( Figures 5 and 6 ). Remarkably, some rare BRs, such as 28-norcastasterone, 28-homobrassinolide, 28-homodolicholide, 28-homodolichosterone, and 22,23-diepi-28-homobrassinolide displayed in contrast a very significant inhibitory effect. Although 24-epi-teasterone proved to be inactive, neither the presence nor the type of C-24 substitution appeared to be absolutely required for BR-induced inhibition of the CPD promoter. The absence or presence of C-2 hydroxylation proved to be even less important, as typhasterol and castasterone which differ at this position showed similar activities (Figures 2b and 5) . However, the fact that ergosterol and cholesterol showed no activity in the assay indicated that 5α-reduction as well as 22-and/or 23-hydroxylation of the side-chain may be essential for efficient feedback inhibition of CPD gene expression.
Discussion
The BR-deficient phenotype of the cpd mutant indicates that in Arabidopsis there is no alternative to CYP90-mediated C-23 hydroxylation of the BR side-chain. Brassinolide-mediated inhibition of CPD gene activity attests to the existence of a negative feedback regulation that controls BR synthesis at this enzymatic step. Since gibberellin biosynthesis is also modulated by a similar mechanism involving expressional regulation of GA 20-oxidases (Phillips et al., 1995) , feedback control seems to represent a mode of self-regulation of phytohormone levels. Whereas our experiments with biosynthetic congeners of brassinolide identified teasterone, the putative product of CYP90, as the first intermediate eliciting substantial inhibitory effect, we also observed a significant (20%) decrease of CPD promoter-uidA expression in transgenic seedlings treated with cathasterone. However, it is currently unknown whether intermediates of the early and late C-6 oxidation pathways of brassinolide are themselves active as hormones or need to be converted to brassinolide, representing the only active steroid hormone. The activity of brassinolide precursors repressing the CPD promoter may therefore solely reflect their position and rate of conversion in the brassinolide biosynthesis pathways . Nonetheless, the CPD inhibitory activity of BRs derived from phytosterols other than campesterol suggests that either other functional steroid hormones synthesized from, e.g. sitosterol, isofucosterol or 24-epi-campesterol (Yokota, 1997) exist in plants or that each BR compound is hormonally active on its own, or both. Whereas the first possibility is supported by detection of sitosterol and isofucosterol-derived compounds in several plant species (Adam et al., 1996; Fujioka and Sakurai, 1997b; Fujioka, 1993, 1997) and the observation that 24-epibrassinolide is the only detectable BR form in Gypsophila perfoliata seeds (Schmidt et al., 1997) , testing of the second possibility would require the characterization of ligand- binding properties of plant steroid receptors. The recent finding that BRI1 codes for a potential transmembrane leucine-rich repeat (LRR)-receptor kinase required for steroid perception may therefore facilitate the functional analysis of different BR compounds .
Apart from exploring possible action mechanisms of plant steroid hormones, the data showing BR-dependent feedback inhibition of CPD transcription are intriguing because they suggest an analogy between end-product regulation of genes involved in animal and plant steroid biosynthesis. In animals, oxidized derivatives of cholesterol carrying one or more hydroxyl groups at positions 7, 20, 22, 25 or 27 regulate both steroidogenic factors (i.e. nuclear steroid receptors) and membrane-bound sterol regulatory element-binding proteins (SREBPs) controlling the activity of genes involved in steroid biosynthesis. The structure of Figure 5 . Screening for brassinosteroids inhibiting the CPD promoter activity. Specific GUS activities were determined after growing Arabidopsis seedlings carrying the CPD promoter-driven uidA reporter construct in the dark for 8 days in MS medium (MS) or in MS medium containing 1 µM of the brassinosteroids listed at the left and in Figure 6 . The data represent an experiment performed with three pools of 20 seedlings. these animal oxysterols differs from those of BRs by the lack of 5α-reduction and C-2 hydroxylation. It may be worth noting a similarity between oxysterols and BRs, because functional conservation of 5α-steroid reductases has been demonstrated between plants and animals and because our data indicate that C-2 hydroxylation of BRs is probably not essential for CPD repression. A further observation pointing to an analogy between sterol feedback regulation in plants and animals is that both oxysterolinduced transcriptional repression in animals and BRmediated inhibition of CPD transcription in Arabidopsis are sensitive to the protein synthesis inhibitor cycloheximide. As known for oxysterol signalling (Brown and Goldstein, 1997; Waterman and Bischof, 1997) , feedback regulation of CPD by BRs seems to require the synthesis or processing (or both) of a negative regulatory factor, which may directly or indirectly control CPD transcription.
To confirm this model, a well-defined 965 bp promoter region is now available for mapping of cis-regulatory sequences controlling CPD transcription in response to BRs. We have shown that BRs repress developmental activation of the CPD promoter in cotyledons during early seedling development and that BR-induced reduction of CPD transcript levels occurs faster in the light than in © Blackwell Science Ltd, The Plant Journal, (1998), 14, 593-602 the dark. The fact that the CPD promoter-uidA reporter construct was found to be active in defined cell types of leaves also suggests that the synthesis and/or stability of CPD mRNA may be controlled in a complex fashion by light and/or developmental signals. Our data regarding developmental activation of the CPD gene raise some immediate questions. Namely, if CPD controlled an essential step of brassinolide biosynthesis, and brassinolide was required for promotion of hypocotyl elongation, why is the CPD gene expression confined to cotyledons and not detectable in actively elongating cells throughout the hypocotyls and roots? Also, if the highest brassinolide levels were detected in pollen and seeds (Mandava, 1988) , why is the CPD gene not expressed in these tissues? In fact, if BRs were the sole regulators of the CPD gene, the absence of CPD gene expression would indicate that the concentration of BRs in these tissues is high enough to repress CPD transcription. However, this model would predict that steroid hormones are efficiently transported from source to target tissues in the plant and/or that BRs are inactivated in the source tissues where the CPD gene (and BR biosynthesis) is active. Translocation of 28-homobrassinolide from the roots to leaves (Schlagnhaufer and Arteca, 1991) , as well as metabolic inactivation of 24-epi-brassinolide by C-25 hydroxylation and subsequent glucosylation (Hai et al., 1995) , were in fact detected in different species. Further isolation of mutants showing changes in tissuespecific regulation of the CPD promoter-driven uidA reporter construct may help to clarify whether these mechanisms indeed play a role in the maintenance of steroid homeostasis in plants.
Experimental procedures
Plant material and growth conditions
Seeds from wild-type Arabidopsis thaliana (ecotype Columbia, Col-1) and derived transgenic plants were surface-sterilized and germinated on MS medium (Murashige and Skoog, 1962) supplemented with 0.5% sucrose and 0.2% Phytagel (Sigma Chemical Co.) at 22°C, either in the dark or under 14 h light/10 h dark cycles, as described by Koncz et al. (1994) . Seedlings were grown for 8 days in the presence of 1 or 10 µM indole-3-acetic acid (IAA), α-naphthaleneacetic acid (NAA), gibberellic acid (GA 3 ), 6-benzylaminopurine (BAP), methyl-jasmonate (JA), salicylic acid (SA), 1-aminocyclopropane-1-carboxylic acid (ACC) or ergosterol to screen for factors affecting CPD promoter activity. The biosynthetic congeners of brassinolide used in the experiments were chemically synthesized .
Construction of transgenic plants carrying a CPD promoter-driven uidA reporter gene
The CPD promoter region, extending from a BamHI site at position -919 to a PCR-generated SmaI site at position ϩ45 (GenBank Accession No. X87368), was PCR-amplified, cloned in pBluescript (Stratagene), and sequenced using a PCR kit (ABI Prism™ Dye Terminator Cycle Sequencing) and an automatic DNA sequencer (ABI 377). The BamHI-SmaI CPD promoter fragment was cloned into BglII-SmaI sites of a polylinker located upstream of the promoterless uidA reporter gene in the promoter test vector pPCV812 (Koncz et al., 1994) . The resulting construct was trans-© Blackwell Science Ltd, The Plant Journal, (1998), 14, 593-602 ferred to Agrobacterium GV3101 (pMP90RK) and transformed into Arabidopsis as described by Koncz et al. (1994) . From transformed root cultures, transgenic plants were regenerated by selecting for the hygromycin resistance marker of pPCV812 T-DNA. After testing the GUS activity in 12 independent transformant lines, seeds from the selfed F 2 families carrying the T-DNA of the pPCV812 construct were screened for by germinating seeds on MS medium containing 15 mg l -1 hygromycin, then bulked for RNA isolation and GUS assays.
Hybridization analysis of steady-state RNA levels
Seedlings were germinated and grown on Phytagel-supported medium for 8 days in the dark or light, then transferred to liquid medium and treated for 2, 4 and 6 h with 100 µM cycloheximide or 1 µM brassinolide (CIDtech Research Inc., Missisauga, Ontario, Canada) under the same light conditions. Other samples were pre-incubated with 100 µM cycloheximide to stop protein synthesis as described by Koshiba et al. (1995) , then treated with 1 µM brassinolide for 2, 4 and 6 h. Control samples were incubated in liquid medium for similar time periods. Aliquots of 25 µg total RNA isolated as described by Nagy et al. (1988) were subjected to Northern blotting (Sambrook et al., 1989) with 32 P-labelled probes generated by random priming using the full-length CPD cDNA (GenBank Accession No. X87367) or the uidA coding region (GenBank Accession No. X02395). Equal loading of filters was controlled as described earlier . Following hybridization, the RNA filters were washed twice with 2ϫ SSC, 0.05% SDS, and twice with 0.1ϫ SSC, 0.1% SDS at 65°C as described previously (Sambrook et al., 1989) , subjected to autoradiography and evaluated quantitatively using a PhosphoImager 445 SI image analyser (Molecular Dynamics Inc., Sunnyvale, CA).
Histochemical and fluorimetric GUS enzyme assays
Histochemical localization of GUS activity was carried out according to Jefferson (1987) with some modifications. Before incubation with 5-bromo-4-chloro-3-indolyl-β-D-glucuronide (X-gluc), the samples were fixed for 10 min in a 2% formaldehyde solution as described by Puente et al. (1996) . Uptake of the staining solution was facilitated by a 10 sec pulse of reduced pressure and verified by control staining of transgenic seedlings ubiquitously expressing the GUS reporter. Following the staining procedure, the samples were washed with 70% ethanol to remove plant pigments. For microscopic examination, leaves were hand-sectioned following the staining process. Spectrofluorimetric assay of GUS activity was performed as described previously (Jefferson, 1987 ) using 4-methyl-umbelliferyl-β-D-glucuronide (MUG) as substrate. GUS enzyme activity was measured at four time points to verify linearity of the reactions. To monitor the effect of phytosterol derivatives repressing the CPD promoter-uidA reporter construct, three pools of 20 seedlings were grown in the dark or light at 22°C for 8 days in MS medium containing 1 µM of the sterol compounds listed in Figure 6 , and subjected to fluorimetric GUS assays. For GUS histochemical analysis, seedlings were grown for 1, 3, 5, 8 or 12 days in the presence or absence of phytosterols under similar conditions, then fixed and treated with staining solution (1 mg ml -1 X-gluc in 50 mM pH 7.0 sodium phosphate buffer containing 0.5 mM potassium ferricyanide and 0.5 mM potassium ferrocyanide) for 12 h. Untreated control samples used for RNA analysis or GUS assay received the same amount of ethanol as was carried over by addition of BR stock solutions.
